Number of the records: 1  

Polymer theranostics with multiple stimuli-based activation of photodynamic therapy and tumor imaging

  1. 1.
    0575824 - ÚMCH 2024 RIV AU eng J - Journal Article
    Tavares, Marina Rodrigues - Islam, R. - Šubr, Vladimír - Hackbarth, S. - Gao, S. - Yang, K. - Lobaz, Volodymyr - Fang, J. - Etrych, Tomáš
    Polymer theranostics with multiple stimuli-based activation of photodynamic therapy and tumor imaging.
    Theranostics. Roč. 13, č. 14 (2023), s. 4952-4973. ISSN 1838-7640. E-ISSN 1838-7640
    R&D Projects: GA MZd(CZ) NU21-08-00280; GA MŠMT LX22NPO5102
    Grant - others:AV ČR(CZ) JSPS-22-01
    Program: Bilaterální spolupráce
    Institutional support: RVO:61389013
    Keywords : fluorescence imaging * photodynamic therapy * pH-responsive theranostics
    OECD category: Polymer science
    Impact factor: 12.4, year: 2022
    Method of publishing: Open access
    https://www.thno.org/v13p4952

    Efficient theranostic strategies concurrently bring and use both the therapeutic and diagnostic features, serving as a cutting-edge tool to combat advanced cancers. Here, we develop stimuli-sensitive theranostics consisting of tailored copolymers forming micellar conjugates carrying pyropheophorbide-a (PyF) attached by pH-sensitive hydrazone bonds, thus enabling the tumor microenvironment-sensitive activation of the photodynamic therapy (PDT) effect, fluorescence or phosphorescence. The nanomedicines show superior anti-tumor PDT efficacy and huge tumor-imaging potential, while reducing their accumulation, and potentially side effects, in the liver and spleen. The developed theranostics exhibit clear selective tumor accumulation at high levels in the mouse sarcoma S180 tumor model with almost no PyF found in the healthy tissues after 48 h. Once in the tumor, illumination at λexc = 420 nm reaches the therapeutic effect due to the 1O2 generation. Indeed, an almost complete inhibition of tumor growth is observed up to 18 days after the treatment. The clear benefit of the specific PyF release and activation in the acidic tumor environment for the targeted delivery and tissue distribution dynamics was proved. Conjugates carrying pyropheophorbide-a (PyF) attached by pH-sensitive hydrazone bonds showed their excellent antitumor PDT effect and its applicability as advanced theranostics at very low dose of PyF.
    Permanent Link: https://hdl.handle.net/11104/0346030

     
    FileDownloadSizeCommentaryVersionAccess
    0575824.pdf08.4 MBLicense CC BYPublisher’s postprintopen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.